Florida-based VITAS Healthcare is taking a more “relationship-based” approach to growth in 2025. The Chemed Corp. (NYSE: CHE) subsidiary’s expanding geographic footprint in Florida has been heavily fueled through organic growth. The prospect of acquisitions is playing a larger role, with the hospice company recently setting its sights on expansion across 12 states. VITAS has […]
Addus Homecare (Nasdaq: ADUS) expects to achieve 5% to 7% hospice growth during 2025. The company’s hospice business is emerging from the shadow of the pandemic, which hurt that business segment considerably more than it did Addus’ home health and personal care service lines. Early and sudden deaths among COVID patients significantly reduced national hospice […]
Enhabit Inc. (NYSE: EHAB) is projecting strong hospice growth in the next year fueled in part by investments in technology and workforce development. The company is currently awaiting for the proverbial dust to settle following its victory in a recent lawsuit and the forthcoming new presidential administration. Enhabit anticipates a “nice bump” in patient census […]
The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Many expect a rebound in 2024, and stirrings in the public company space signal that may come […]
BrightSpring Health Services, Inc. has begun trading on the NASDAQ under the stock symbol BTSG. BrightSpring is a home- and community-based health care services platform that serves more than 400,000 patients daily. The company indicated its intent to go public in a Jan. 3 filing with the U.S. Securities and Exchange Commission, expecting a $1 […]
Nearly a year after shying away from becoming an initial public offering (IPO), BrightSpring Health Services Inc. has allegedly re-filed, this time with a much higher valuation. The company, which does not yet have a stock symbol, raised the bar from when it initially filed in October 2021 with a $100 million listing. BrightSpring later […]
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority. But this […]
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]
Private equity (PE) firms represent the strongest competitors for strategic buyers in the hospice mergers-and-acquisitions market. Hospice M&A activity cooled off across the board during the first quarter of 2022. In part, this is because a range of buyers scrambled to complete deals during late 2021 and are now focused on integrating those assets. But […]
In its calculus behind its 2021 Kindred at Home deal, Humana Inc. (NYSE: HUM) had to weigh the potential cost savings and lucrative hospice divestiture against the labor pressures in the space, as well as the complexity of scaling home-based care in a fragmented industry. Last year, Humana acquired total ownership of Kindred at Home […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
